Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus

Original Article

R.A. Furie, M. Dall’Era, E.M. Vital, J.P. Garg, F.I. Palazuelos, A.E.Z. Santillán, J. Ravelo-Hernández, M.B. Santiago, B.Z. Montiel, S. Botha, P. Leszczyński, V.A.d. Souza, S.A. Sicsik, L. Bellatin, A. Naidoo, Z. Amoura, M.A. D’Agostino, S. Kumar, B. Workeneh, J. Rae, H.A. Mao, F. Erblang, O. Meier, J.C. Maller, and A.D. Askanase

N Engl J Med 2026;395:243-254

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
07/15/2026
Course expires: 
07/16/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.